Status:
UNKNOWN
Far Infrared Therapy on Peritoneal Function of CAPD Patients
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Conditions:
End-stage Renal Disease
Eligibility:
All Genders
18-90 years
Phase:
PHASE3
Brief Summary
For patients with end-stage renal disease, peritoneal dialysis (PD) has been proven to be an alternative choice compared to hemodialysis as a type of maintenance renal replacement therapy. Despite thi...
Detailed Description
A total of 100 CAPD patients will be enrolled in this study, including 50 in treatment group who will receive FIR therapy for 6 months and 50 in control group. Many parameters of blood and urine sampl...
Eligibility Criteria
Inclusion
- Chronic peritoneal dialysis patients who have not received any FIR therapy within the previous 12 months
- Patients on a standard continuous ambulatory peritoneal dialysis (CAPD) (1.5-2 L; 4-5 exchanges/day) or ambulatory peritoneal dialysis (APD) program
Exclusion
- History of CAPD-related peritonitis within 3 months prior to the study period;
- History of cerebrovascular accident or myocardial infarction or interventional procedure (percutaneous transluminal coronary angioplasty or stent) for coronary artery disease within the 3 months prior to the study
Key Trial Info
Start Date :
January 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04344067
Start Date
January 1 2016
End Date
June 30 2020
Last Update
April 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Veterans General Hospital
Taipei, Taiwan, 11217